发明名称 Polypeptide biomarkers for diagnosing Alzheimer's disease
摘要 <p>A method for assessing the state of Alzheimer's disease in patients is disclosed. A method for monitoring the progression of Alzheimer's disease in patients is also disclosed. The method applies detection of specific markers in body fluids (e.g. CSF), using mass spectrometric analysis (SELDI-TOF MS). The specific markers are: human cystatin C, human beta-2-microglobulin, human myoglobin neurosecretory protein VGF or fragments of these proteins.</p>
申请公布号 EP2221620(A3) 申请公布日期 2010.11.24
申请号 EP20100164475 申请日期 2003.08.11
申请人 BAYER SCHERING PHARMA AG 发明人 YALKINOGLU, OEZKAN, DR.;KOENIG, GERHARD, DR.;HOCHSTRASSER, DENIS FRANCOIS, PROF.DR.;SANCHEZ, JEAN-CHARLES, DR.;CARETTE, ODILE, DR.
分类号 G01N27/62;G01N33/68;C07K14/47;C07K14/74;C07K14/805;C07K14/81;C12Q1/37;G01N33/53 主分类号 G01N27/62
代理机构 代理人
主权项
地址